Not recruiting
Hepatitis B virus test+1
Not recruitingStudy on the Effects of Selgantolimod and NUC Discontinuation in Patients with Chronic Hepatitis B
Registered drugNo placebo
Study on the Effects of Selgantolimod and NUC Discontinuation in Patients with Chronic Hepatitis B
Registered drugNo placebo
- Disease:Hepatitis B virus testHepatitis B e antigen negative
- Substances:Selgantolimod
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Selgantolimod
- Sponsor:ANRS Maladies Infectieuses Emergentes



